tiprankstipranks
Trending News
More News >
PainChek Ltd (AU:PCK)
ASX:PCK
Australian Market
Advertisement

PainChek Ltd (PCK) Price & Analysis

Compare
10 Followers

PCK Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.03%95.97%
Mutual Funds
― Other Institutional Investors
95.97% Public Companies and
Individual Investors

PCK FAQ

What was PainChek Ltd’s price range in the past 12 months?
PainChek Ltd lowest share price was AU$0.02 and its highest was AU$0.06 in the past 12 months.
    What is PainChek Ltd’s market cap?
    PainChek Ltd’s market cap is AU$73.68M.
      When is PainChek Ltd’s upcoming earnings report date?
      PainChek Ltd’s upcoming earnings report date is Aug 29, 2025 which is in 31 days.
        How were PainChek Ltd’s earnings last quarter?
        Currently, no data Available
        Is PainChek Ltd overvalued?
        According to Wall Street analysts PainChek Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does PainChek Ltd pay dividends?
          PainChek Ltd does not currently pay dividends.
          What is PainChek Ltd’s EPS estimate?
          PainChek Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does PainChek Ltd have?
          PainChek Ltd has 1,842,056,000 shares outstanding.
            What happened to PainChek Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of PainChek Ltd?
            Currently, no hedge funds are holding shares in AU:PCK

            PainChek Ltd Stock Smart Score

            Company Description

            PainChek Ltd

            PainChek Ltd (PCK) is a technology company that operates in the healthcare sector, specializing in the development and commercialization of innovative pain assessment tools. Its core product is the PainChek app, which utilizes artificial intelligence and facial recognition technology to assess and score pain levels in individuals who may have difficulty communicating, such as those with dementia or cognitive impairments. The company aims to improve pain management and enhance patient care through its advanced digital health solutions.
            Similar Stocks
            Company
            Price & Change
            Follow
            Imugene
            Paradigm Biopharmaceuticals
            CardieX
            Resonance Health Ltd
            BCAL Diagnostics Limited
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis